Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysis

There is controversy whether IL-6 (receptor) antagonists are beneficial in treating COVID-19 patients. We therefore update our systematic review to answer the following research questions: (1) Do patients hospitalized for COVID-19 treated with IL-6 (receptor) antagonists have lower mortality compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Malgie, Jishnu, Schoones, Jan W., Zeegers, Maurice P., Pijls, Bart G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564515/
https://www.ncbi.nlm.nih.gov/pubmed/34728658
http://dx.doi.org/10.1038/s41598-021-00726-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564515/
https://www.ncbi.nlm.nih.gov/pubmed/34728658
http://dx.doi.org/10.1038/s41598-021-00726-4

Ejemplares similares